세계 고관절 치환술 시장 규모는 2023년 71억 5,000만 달러에서 2031년 126억 1,000만 달러에 달할 것으로 예상되며, 예측 기간인 2024-2031년간 연평균 7.35% 성장할 것으로 예상됩니다. 고령화, 기술 발전, 라이프 스타일 관련 요소, 골관절염 및 고관절 골절의 유행, 환자 인식 증가, 의료 지출 증가 등 다양한 요인이 세계 고관절 치환술 시장의 역학을 형성하고 있습니다.
세계 고관절 치환술 시장의 최전선은 고령화이며, 노년층은 고관절 골절 및 고관절 골절과 같은 고관절 치환술이 필요한 질환의 유병률이 높기 때문에 매우 중요한 촉매제 역할을 하고 있습니다. 동시에 최소 침습 수술과 임플란트 재료의 개선 등 기술 혁신을 통한 이 분야의 발전은 수술 결과를 개선하고 환자 경험을 개선하는 데 기여하고 있습니다.
좌식 생활과 비만율 증가와 같은 생활습관 요인이 고관절 치환술에 대한 수요 증가에 크게 기여하고 있습니다. 현대인의 생활습관이 관절 건강에 영향을 미치면서 사람들이 의료적 개입을 요구하고 있으며, 이는 세계 고관절 치환술 시장의 성장을 견인하고 있습니다. 골관절염과 고관절 골절 증가는 고관절 치환술의 주요 적응증이기 때문에 이러한 추세를 더욱 가속화하여 세계 고관절 치환술 시장의 성장을 가속하고 있습니다.
전 세계적으로 의료비 지출이 증가하고 있으며, 고관절 치환술과 같은 선택적 수술을 포함한 첨단 의료에 대한 접근성이 향상되고 있습니다. 또한, 환자들의 인식이 높아지면서 세계 고관절 치환술 시장의 성장을 견인하고 있습니다. 고관절 치환술의 이점에 대한 사람들의 정보 수집이 증가하여 더 큰 수용과 수요를 촉진하고 있습니다. 세계 고관절 치환술 시장의 유명 기업들은 자사 제품의 장점에 대한 사회적 인식을 높이기 위해 다양한 마케팅 활동을 수행하고 있습니다.
예를 들어, 2023년 8월 세계 의료기술 기업 스트라이커(Stryker)는 'Scan. Plan. Mako Can.'이라는 제목의 전국적인 마케팅 활동을 시작했습니다. 이 캠페인은 특히 무릎 관절염, 고관절 등 인공관절 치환술이 필요한 환자들을 위한 혁신적인 솔루션인 마코 스마트 로봇(Mako SmartRobotics)에 대한 환자들의 인지도를 지속적으로 향상시키기 위해 기획됐습니다.
세계 고관절 치환술 시장의 급격한 성장은 현대인의 생활습관과 관련된 질환 증가에 기인하는 것으로 보입니다. 앉아서 생활하는 생활습관, 불충분한 신체활동, 비만율 증가로 특징지어지는 현대인의 생활방식은 관절 건강 악화에 큰 기여를 하고 있습니다. 이러한 생활습관은 고령화와 함께 골관절염이나 고관절 골절과 같은 질환의 발생 증가에 중요한 역할을 하고 있으며, 고관절 치환술의 도입이 필요하게 되었습니다. 현재의 비활동적인 생활 습관과 비만 유행은 관절에 더 많은 부담을 가하고 마모와 손상 과정을 가속화합니다. 그 결과, 고관절 치환술과 같은 의학적 개입이 필요한 상태에 빠지기 쉽습니다.
통증을 완화하고, 이동성을 개선하고, 전반적인 삶의 질을 향상시키기 위한 솔루션을 적극적으로 찾는 사람들이 증가함에 따라 시장은 수요 증가를 경험하고 있습니다. 기본적으로 세계 인공고관절 시장의 성장은 현대인의 라이프스타일이 관절 건강에 미치는 영향과 밀접한 관련이 있습니다. 이러한 생활습관 관련 질환의 유병률이 증가함에 따라 고관절 치환술에 대한 수요가 급증하고 있으며, 이는 시장 확대를 견인하고 있습니다.
지속적인 기술 발전은 세계 고관절 치환술 시장의 성장에 박차를 가하고 있습니다. 최소 침습 수술, 첨단 임플란트 재료, 로봇 보조 수술의 통합과 같은 획기적인 발전으로 고관절 치환술의 정확성과 유효성이 크게 향상되고 있습니다. 이러한 혁신은 환자의 예후를 개선할 뿐만 아니라 회복 기간을 단축하고 수술 후 합병증을 감소시키는 데에도 기여하고 있습니다. 의료 서비스 제공업체와 제조업체들이 계속해서 첨단 기술을 도입하면서 세계 고관절 치환술 시장은 지속적으로 진화하고 있으며, 환자들에게 관절 관련 문제에 대한 보다 진보되고 개인화된 솔루션을 제공합니다.
이 보고서는 세계 고관절 치환술 시장에 대해 조사 분석했으며, 시장 규모와 예측, 시장 역학, 주요 기업 현황과 전망 등을 전해드립니다.
Global hip replacement market is projected to witness a CAGR of 7.35% during the forecast period 2024-2031F, growing from USD 7.15 billion in 2023 to USD 12.61 billion in 2031. Various factors shape the dynamics of the global hip replacement market, including an aging population, advancements in technology, lifestyle-related elements, the prevalence of osteoarthritis and hip fractures, heightened patient awareness, and increased healthcare expenditure.
At the forefront of the global hip replacement market is the aging population, acting as a pivotal catalyst, as the elderly demographic exhibits a heightened prevalence of conditions necessitating hip replacement procedures, such as osteoarthritis and hip fractures. Simultaneously, the field advances through technological innovations, including minimally invasive surgeries and improved implant materials, contribute to enhanced surgical outcomes and overall patient experiences.
Significantly, lifestyle factors, encompassing sedentary habits and increasing obesity rates, significantly contribute to the growing demand for hip replacement surgeries. As contemporary lifestyles impact joint health, individuals seek medical interventions, propelling expansion of the global hip replacement market. The prominence of osteoarthritis and hip fractures further amplifies this trend, given their status as primary indications for hip replacement procedures boosting the growth of global hip replacement market.
There is a global upswing in healthcare expenditure, facilitating improved access to advanced medical treatments, including elective procedures like hip replacements. Furthermore, the growth of global hip replacement market is propelled by heightened patient awareness. Individuals are becoming increasingly informed about the advantages of hip replacement surgeries, fostering greater acceptance and demand. Prominent companies in the global hip replacement market are implementing diverse marketing initiatives to raise public awareness regarding the advantages of their products.
For instance, in August 2023, Stryker, a prominent global medical technology company, revealed the initiation of a nationwide marketing initiative directly targeting patients titled "Scan. Plan. Mako Can." This campaign is designed by Stryker to persistently improve awareness among patients about Mako SmartRobotics, an innovative solution tailored for individuals requiring joint replacement surgery, specifically for knee or hip arthritis.
The surging expansion observed in the global hip replacement market can be ascribed to the upswing in ailments associated with contemporary lifestyles. The modern way of life, characterized by sedentary lifestyle, insufficient physical activity, and escalating obesity rates, significantly contributes to the degradation of joint health. These lifestyle elements, combined with an aging population, play a pivotal role in the increased occurrence of conditions like osteoarthritis and hip fractures, necessitating the adoption of hip replacement surgeries. The inactive nature of current lifestyles and the prevalence of obesity impose additional strain on joints, hastening the process of wear and tear. Consequently, individuals are more susceptible to developing conditions requiring medical interventions, such as hip replacement procedures.
The market is experiencing a rise in demand as individuals actively seek solutions to mitigate pain, improve mobility, and enhance their overall quality of life. Fundamentally, the growth observed in the global hip replacement market is intricately connected to the repercussions of contemporary lifestyles on joint health. With the prevalence of these lifestyle-related ailments on the rise, there is a corresponding surge in the demand for hip replacement surgeries, propelling the market's expansion.
Persistent technological advancements are fueling the expansion of the global hip replacement market. Breakthroughs like minimally invasive procedures, state-of-the-art implant materials, and the integration of robotic-assisted surgeries have markedly improved the accuracy and effectiveness of hip replacements. Beyond improving patient outcomes, these innovations also lead to shorter recovery periods, diminishing post-surgical complications. With healthcare providers and manufacturers increasingly adopting cutting-edge technologies, the global hip replacement market is in a constant state of evolution, presenting patients with progressively advanced and personalized solutions for joint-related concerns.
As an example, in June 2023, the Asian Orthopaedic Institute at SIMS Hospital in Vadapalani introduced a fully equipped unit for hip surgery along with four advanced technology services. The institute introduced the Chicago Hip Preservation Service, the NAVISWISS system, custom docking augment technology, and a hip resurfacing system. The primary goal behind the launch of the Chicago Hip Preservation Service was to identify, detect, and address issues before the onset of painful arthritis.
The increasing desire for Revision Hip Implants is a pivotal force driving the growth of the global hip replacement market. These implants are vital in rectifying situations where a previously implanted hip replacement necessitates modification or replacement due to issues like wear, loosening, or other complications. With an aging population on the rise and a growing number of individuals undergoing initial hip replacement procedures, the demand for revision surgeries is escalating. This heightened demand highlights the significance of advanced technologies and innovative solutions in the hip replacement market, underscoring its adaptability to evolving healthcare needs and its commitment to enhancing patient outcomes.
In November 2023, Biocomposites, a global medical devices company specializing in the engineering, manufacturing, and marketing of leading products for infection management in bone and soft tissue, is delighted to announce the introduction of SYNICEMTM hip, knee, and shoulder preformed spacers in the United Kingdom. They provide valuable support to surgeons in revising the hip, knee, and shoulder, preserving articular space, and facilitating the treatment of infections.
The escalating adoption of hip replacements in hospitals and surgical centers is a pivotal factor propelling the expansion of the global hip replacement market. This trend is primarily driven by the rising incidence of hip-related disorders and an aging population globally. Hospitals and surgical centers, equipped with advanced medical technologies and skilled healthcare professionals, play a crucial role in meeting the increasing demand for hip replacement procedures. The growing awareness of the benefits of hip replacements and advancements in surgical techniques and implant materials further contribute to the market's growth as individuals seek improved mobility and quality of life through these medical interventions.
For instance, in August 2022, Exactech, a company specializing in innovative implants and smart technologies for joint replacement surgery, reported the successful initial surgeries of the Spartan Stem and Logical Cup System for total hip arthroplasty. The Logical Cup, an advanced modular acetabular system, is designed to address the needs of highly active patients while streamlining surgical procedures in both hospitals and ambulatory surgical centers, improving efficiency and meeting the demand of modern joint replacement surgeries.
The Asia-Pacific region is experiencing substantial growth within the global hip replacement market. Drivers of this expansion encompass a swiftly aging population, a heightened incidence of lifestyle-related joint issues, and a rising awareness of advanced medical interventions. Additionally, the market is propelled forward by ongoing technological advancements in hip replacement procedures and an upsurge in healthcare investments. With the increasing demand for hip replacements spurred by these factors, the Asia-Pacific emerges as a pivotal contributor to the overall dynamic transformation of the global hip replacement market.
For example, in August 2023, the UK-based medical technology company Smith+Nephew unveiled its OR3O Dual Mobility System designed for application in both primary and revision hip arthroplasty procedures in India. Distinguished from conventional solutions, dual mobility implants feature a smaller diameter femoral head that securely engages with a larger polyethylene insert. This design enhances stability, diminishes the risk of dislocation, and provides an improved range of motion compared to traditional alternatives.
Progress in materials and robotics will lead to advancements, enhancing the durability and precision of implants in worldwide hip replacement procedures.
The growing elderly population will drive demand, fueled by an increase in age-related joint issues, propelling global hip replacement market expansion.
Customization trends will experience a surge, with personalized hip replacements shaped by 3D printing and advanced imaging, optimizing both fit and functionality.
Healthcare investments and increased awareness in developing nations will facilitate growth of the global hip replacement market, providing broader access to hip replacement surgeries globally.
Key participants in the worldwide hip replacement market are proactively seeking mergers and acquisitions to strengthen their market standing and meet the increasing demand for orthopedic solutions. These strategic maneuvers empower companies to improve their product arrays, acquire novel technologies, and optimize operations for increased efficiency. Collaborative efforts from mergers and acquisitions facilitate the exchange of expertise and resources, ultimately propelling innovation in hip replacement technologies. This industry consolidation not only enables economies of scale but also stimulates competition, improving patient access to advanced and diverse hip replacement alternatives on a global level.
For example, Zimmer Biomet Holdings, Inc., a leading global medical technology company, disclosed in May 2023 its finalized agreement to acquire OSSIS. This privately held medical device firm specializes in customized 3D printed implants and intricate hip replacements, encompassing procedures such as secondary hip replacements and replacements associated with bone tumors and trauma.
All segments will be provided for all regions and countries covered:
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.